Singapore Pharmaceutical Consulting
Singapore’s pharmaceutical market is worth about $800m. Despite its small population of around 5 million people, Singapore’s affluence and notable health awareness has led to increased drug demand. PBM’s Singapore pharmaceutical consultants have helped international companies navigate through the country’s pharmaceutical market by offering consulting services in partner searches, setting up business ventures, marketing and distribution of drugs and in performing product registration in the Singapore drug market.
It is imperative that international companies understand the healthcare environment in Singapore. With very good research and development capabilities and advanced manufacturing technology, many international pharmaceutical companies have established their own drug production facilities in Singapore. These include drugs to treat respiratory and gastrointestinal diseases as well as cholesterol and neurological illnesses. In terms of disease profile, the leading causes of death in Singapore are cancer, pneumonia, cardiovascular disease.
Singapore’s regulation of drugs falls under the responsibility of the Health Products Regulation Group, which is a part of the Health Sciences Authority (HSA). The HSA ensures the overall quality, safety and efficacy of drugs, medical devices, cosmetics, and other health related products in Singapore.
International drug companies looking to expand their business into Singapore via product distribution or establishment of local manufacturing facilities can contact a PBM pharmaceutical consultant for assistance and professional advice.
PBM’s Singapore pharmaceutical consultants possess the experience and expertise to help international companies grow in this market. We dedicate our efforts to ensure that our clients’ business goals are achieved. For inquiries about PBM’s Singapore pharmaceutical consultant services, please contact us or view PBM’s publications for more discussions on Singapore’s healthcare market.
